NCT00412919View on ClinicalTrials.gov

Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

PHASE2TerminatedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Multiple Myeloma

Interventions

DRUG

Azacitidine

Trial Locations (1)

3004

The Alfred Hospital, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayside Health

OTHER_GOV